Early Predictors of the Response to Adalimumab Therapy in Patients With Juvenile Idiopathic Arthritis Without Systemic Manifestations: A Prospective Cohort Study

Early Predictors of the Response to Adalimumab Therapy in Patients With Juvenile Idiopathic Arthritis Without Systemic Manifestations: A Prospective Cohort Study

Background. Tumour necrosis factor alpha inhibitors are widely used in the treatment  of juvenile idiopathic arthritis (JIA). To achieve maximum efficiency of genetically engineered biologic drugs, it is necessary to study predictors of the response to therapy. Objective. Our aim was to identify ear...

Full description

Saved in:
Bibliographic Details
Main Authors: Ekaterina I. Alexeeva, Tatyana M. Dvoryakovskaya, Kseniya B. Isaeva, Tatyana V. Sleptsova, Rina V. Denisova, Margarita A. Soloshenko, Olga L. Lomakina, Anna N. Fetisova, Mariya G. Rudnickaya, Dariya D. Vankova, Yuri M. Dyakonov, Alina A. Alshevskaya, Andrei V. Moskalev, Anna V. Mamutova
Format: Article
Language:English
Published: "Paediatrician" Publishers LLC 2018-12-01
Series:Вопросы современной педиатрии
Subjects:
children
juvenile idiopathic arthritis
therapy
response predictors
genetically engineered biologic drug
adalimumab
Online Access:https://vsp.spr-journal.ru/jour/article/view/1954
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items